Patents
Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
10/2005
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581232A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
09/2005
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005003104A3 Crystalline forms of lamotrigine monohydrate and anhydrous lamotrigine and a process for their preparation
09/22/2005US20050209453 Processes for producing 2,4,6-tris(hydroxyphenyl amino)-1,3,5-triazines and 2,4,6-tris(substituted phenylamino)-1,3,5-triazines
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2151604C Application of riluzole in the treatment of neurological lesions associated with traumas
09/15/2005US20050202973 Aryl-alkyne compounds as herbicides
09/15/2005DE4330281B9 Verfahren zur Insektenbekämpfung Method for insect control
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/13/2005US6943249 recrystallizing from a polar aprotic solvent (dimethylsulfoxide, dimethylformamide, dimethylacetamide, or N-methylpyrrolidinone) and a cosolvent (acetonitrile, ethanol, methylethyl ketone, isopropyl alcohol, or 1-propanol); myelodysplastic syndrome
09/09/2005WO2005082867A1 Novel 1,2,4-benzotriazine-1,4-dioxides
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/01/2005WO2005080354A1 1,2,4-triazines derivatives, preparation thereof and use thereof in human therapeutics
09/01/2005US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity
09/01/2005CA2555263A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
08/2005
08/31/2005EP1347978B1 Novel substituted imidazotriazinones as pde ii-inhibitors
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/11/2005WO2005072361A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
08/11/2005CA2554387A1 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
08/10/2005EP1560488A2 Antibacterial agents
08/10/2005CN1653025A NK1 antagonists
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/04/2005US20050171107 Crystal forms of lamotrigine and processes for their preparations
08/04/2005US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1558589A2 Compounds, compositions, and methods
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1648122A Malononitrile compounds and its use
08/02/2005US6924251 herbicides.
07/2005
07/28/2005WO2005068446A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof
07/27/2005EP1556341A1 Process for preparing a pharmaceutically active compound and for preparing its intermediate
07/20/2005EP1555259A1 Malononitrile compounds as pesticides
07/14/2005US20050153961 to hypoxic tumor cells and aerobic cells following or preceding a hypoxic incubation of the cells with the drug; ability to kill hypoxic cells directly; in vitro and in vivo; substitution in position 3 determines desired activity for compound
07/13/2005EP1551834A1 Substituted quinazolinone compounds
07/07/2005WO2004082822A3 Methods for isolating crystalline form i of 5-azacytidine
07/07/2005US20050148773 labeling reagents; powerful tools for analyte analysis, including but not limited to multiplex proteomic analysis; comprises one or more heavy atom isotopes; intermediates in the synthesis of active esters of N-substituted piperazine acetic acid
07/07/2005US20050148771 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
07/07/2005DE10356099A1 Organisches Elektrolumineszenzelement An organic electroluminescent
07/06/2005EP1549614A2 Vasculostatic agents and methods of use thereof
07/05/2005CA2160928C Compounds as pde iv and tnf inhibitors
06/2005
06/29/2005EP1246624B1 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/28/2005US6911449 For treating osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinu -ria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/16/2005WO2005054199A1 Tubulin inhibitors
06/16/2005CA2857067A1 Tubulin inhibitors
06/16/2005CA2545422A1 Tubulin inhibitors
06/15/2005EP1539720A1 New process for the synthesis of high purity 3,5-diamino-6-(2, 3-dichlorophenyl)-1,2,4-triazine
06/14/2005US6906068 Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
06/09/2005WO2005053055A1 Organic electroluminescent element
06/09/2005WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005CA2545601A1 Quinazolinone compounds with reduced bioaccumulation
06/02/2005US20050119265 Novel crystalline forms of lamotrigine
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
05/2005
05/31/2005US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
05/19/2005WO2005035500A3 Therapeutic agents useful for treating pain
05/19/2005US20050107385 Aromatic prodrugs of propofol, compositions and uses thereof
05/19/2005US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide
05/19/2005DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/17/2005US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus
05/17/2005US6894046 For treating eosinophil-dependent inflammatory diseases, asthma
05/12/2005US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate
05/11/2005EP1397363B1 5-ethyl-imidazotriazinones
05/11/2005EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
05/04/2005CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
05/04/2005CN1199640C 1,2,4-triazin-3-ones, their derivative substituted 4,5-dihydro-1,2,4-triazin-3-ones, and their use as fungicides and insecticides
04/2005
04/28/2005WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/28/2005WO2004092125A3 Using alkylmetal reagents for directed metalation of azaaromatics
04/28/2005CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/27/2005EP1524974A2 Transcription factor modulating compounds and methods of use thereof
04/27/2005EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same
04/26/2005US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases
04/21/2005WO2005035500A2 Therapeutic agents useful for treating pain
04/21/2005US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
04/20/2005EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
04/19/2005CA2116631C Process for the preparation of aqueous nicotinaldehyde
04/14/2005US20050079979 Substituted benzoylisoxazoles and the use thereof as herbicides
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/07/2005US20050075339 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/07/2005US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials
04/07/2005DE4330281B4 Verfahren zur Insektenbekämpfung Method for insect control
03/2005
03/31/2005WO2005007634A8 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/24/2005WO2005025681A2 A system for and a method of manufacturing personal golf putters
03/24/2005US20050065153 Antiinflamamtory agents; respiratory system disorders; autoimmune disease
03/23/2005CN1597672A Substituierte benzoylcyclohexandione
03/17/2005WO2005023204A2 Aromatic prodrugs of propofol, compositions and uses thereof
03/17/2005US20050059662 Substituted quinazolinone compounds
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 30